IndraLab

Statements


USP18 activates mutated KRAS. 1 / 1
| 1

reach
"These findings showed that reduced USP18 levels can antagonize growth of KRAS mutant lung cancers, Yet, destabilization of ISGylated proteins downstream of KRAS might also be responsible for the growth inhibition observed after USP18 loss."